Complementary Oligonucleotide Probe of Vesicular Stomatitus Virus Matrix Protein mRNA Translation  by Wickstrom, Eric et al.
2. Stoffler, G., and M. Stoffler-Meilicke. 1984. Immunoelectron
microscopy of ribosomes. Annu. Rev. Biophys. Bioeng. 13:303-
330.
3. Lambert, J. M., G. Borleau, J. A. Cover, and R. R. Traut. 1983.
Crosslinks between ribosomal proteins of 30S subunits in 70S
tight couples and in 30S subunits. Biochemistry. 22:3913-3920.
4. Nomura, M. 1973. Assembly of bacterial ribosomes. Science (Wash.
DC). 179:864-873.
5. Cooperman, B. S. 1980. Functional sites on the E. coli ribosome as
defined by affinity labelling. In Ribosomes: Structure, Function
and Genetics. G. Chambliss, G. R. Craven, J. Davies, K. Davis, L.
Kahan, and M. Nomura, editors. University Park Press, Balti-
more. 531-554.
6. Lake, J. A. 1985. Evolving ribosome structure: domains in archae-
bacteria, eubacteria, eocytes, and eukaryotes. Annu. Rev. Bio-
chem. 54:507-530.
COMPLEMENTARY OLIGONUCLEOTIDE PROBE
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We decided to predict the secondary structure of a messen-
ger ribonucleic acid (mRNA), then pick a single-stranded
region as a target for hybridization arrest by complemen-
tary oligonucleotides (1), and test the predictions in vitro.
Translation of Rous sarcoma virus RNA was inhibited in
vitro by a tridecanucleotide complementary to a site near
its 5' end, with a 50% inhibition dose of -100 nM (1).
Translation of all five vesicular stomatitis virus (VSV)
mRNA was inhibited in mouse L cells by a methylphos-
phonate octanucleotide complementary to the ribosome
binding site of the N protein mRNA, with a 50% inhibition
dose of- 150 ,uM (2).
VSVmatrix protein (M) is a 26,024 d polypeptide coded
by an mRNA with 831 nucleotides (nt) (3). The mRNA is
translated on free polyribosomes in the cytoplasm (4), so it
may be more accessible than in membrane-bound polyri-
bosomes. Its prominence and separation from other VSV
proteins on polyacrylamide gels (5), as well the modest size
of its mRNA, identified it as a plausible model system for
complementary oligonucleotide probes.
MATERIALS AND METHODS
RNA secondary structures were predicted with the program RNAFLD
(6). Equilibrium constants for the association of oligonucleotides with
predicted single-stranded regions of VSV M mRNA were calculated at
370C from nearest-neighbor enthalpies and entropies of base pairing (7).
No correction of the free energies was made for RNA-DNA hybridiza-
tion, instead of RNA-RNA hybridization, nor was any correction made
for topological constraints on RNA loops or bulges.
Oligonucleotides were synthesized (8) on an Applied Biosystems
(Foster City, CA) oligonucleotide synthesizer, purified by gel electropho-
resis, and sequenced chemically (9). The full length M gene was isolated
as a Pst I fragment of the plasmid pM309 (3).
VSV mRNAs were isolated from infected baby hamster kidney (BHK)
cells as described (5). VSV mRNAs were translated in rabbit reticulocyte
lysate (Promega Biotec, Madison, WI), in the presence of [35S]Met, 1064
Ci/mol (New England Nuclear, Boston, MA), with or without added
oligonucleotides. The oligonucleotides and mRNA were annealed for 3
min at 520C, then cooled for 10 min at room temperature prior to
translation. Labeled translation products were analyzed by hot 5%
trichloroacetic acid precipitation and by 10% polyacrylamide gel electro-
phoresis (10) followed by fluorography.
RESULTS
A potential secondary structure for the 5' half of the VSV
M mRNA was calculated (Fig. 1), and then a structure
was calculated for the entire 831 nt message (Fig. 2). In
Fig. 1, nucleotides 17-31 appear to form a single-stranded
bulge, a likely target for a complementary oligonucleotide;
this site is midway between the cap and the initiation
codon. In Fig. 2, nucleotides 37-46 form a somewhat
smaller single-stranded bulge, which is thus a less favor-
able target for a complementary oligonucleotide. However,
this site includes the initiation codon.
Thermodynamic calculations (7) at 370C for the asso-
ciation of 5'-TTGGGATAACACTTA-3' with nucleotides
17-31 of the structure in Fig. 1 yield an association
constant of 2.0 x 105/M. The calculated association
constant drops to 6.2 x 106/M if one assumes the secon-
dary structure calculated for the entire sequence (Fig. 2).
When total VSV mRNA was translated in rabbit reticu-
locyte lysate with added 5'-TTGGGATAACACTTA-3',
we observed inhibition of overall VSV mRNA translation
(Table I) with 50% inhibition at -14 ,uM. Polyacrylamide
gel electrophoresis revealed that production of all VSV
proteins was inhibited equally (not shown). Brome mosaic
virus mRNA translation was also inhibited nonspecifically,
with 50% inhibition at 45,uM observed with a penta-
decamer complementary to nucleotides 37-46 (unpub-
lished results). Hybridization arrest ofM mRNA transla-
tion occurred after annealing with the full length M gene,
the Pst I fragment of pM309. The M band on a gel
fluorograph was reduced by 83%, relative to the N band,
compared with a control lane of labeled VSV proteins.
DISCUSSION
Coordinate suppression of all VSV mRNA translation by
the complement ofM mRNA nucleotides 17-31 correlates
with a similar observation for N mRNA (2), and suggests
BIOPHYS. J. © Biophysical Society * 0006-3495/86/01/15/03 $1.00 15
Volume49 January 1986 15-17
90-
100
AAAUU
AG AG
A G
U G
C A
*U
A C
A G
AGAA CCAC
U-A 110
80 -AG-G-C
AA-G-C
G-C
G-C
G-C
A-U
A-U-120
70G AU G
C
U
c
150-C G
U A
C-G
U-G-CoAO-G-CG
A-U
G-C
I 140-G-C-160
U-A
A AU
C C A
G-C-200
A-U
CU-A
A-U
C-G
130_A_UA
G-C 19
G-C
AAGA G
A
210-A
GGUAUAGAAUUA A C UGC-G20
U-A
C-GA
U-A
60U- 230uC UA
G-C 260-A A
A-U G U
A-U A C
G-C U G
A-U U U
A-U G-C-270
A-U G-C
U-A-240 C-Gt.U-AC A-UU
50-C-% G-C
C-G 250-U-A
U-A A A A G
U-A U A q A A
G-C 280
A-U
IUA U
''-G 310-A U
40-U-A C-G
A-U-290 C-G
uIU-C-G C-G
A-C-G U-A
39 C-G A-U
C C CAA U C U-A
U A G-C-320
A G 300 U-A
U C C G C U
U G
G
U G A A U C C A
26 U-A
u
GA CU A
C A
A-U 170
G-C
G-C,UU-A
A-U
GU
90-A-U
G-U
C-G- 180
A G
G A
U G
U
A-U
G-C A C
C-G-330 A G
10AC-G A U
.U-A G-C
`SU-A 340-G-C
A-U G-C-350
7MG-AACAG GGCA .3'
FIGURE 1 Calculated secondary structure of the 5' 350 nucleotide of the
VSV M mRNA, with the initiation codon outlined. Residues 17-31
appear in a single-stranded bulge, a potential target for hybridization
arrest.
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FIGURE 2 Calculated secondary of the entire VSV M mRNA, with the
initiation codon outlined. Residues 37-46 appear in a single-stranded
bulge, a potential target for hybridization arrest.
the possibility of coordinate regulation of translation by
both the M and the N proteins. However, the weaker
inhibition of BMV mRNA implies that the pentadecanu-
cleotide used may also have inhibited the rabbit reticulo-
cyte ribosomes nonspecifically, as seen before (1). No
sequence homology is immediately apparent between the
pentadecamer and BMV mRNA or rabbit 18S rRNA.
The concentration required for 50% inhibition is far higher
than would be expected from Fig. 1 and the corresponding
association constant, but is only two orders of magnitude
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TABLE I
PERCENT INHIBITION OF mRNA TRANSLATION
BY 5'-TTGGGATAACACTTA-3'
15-mer mRNA
concentration,,M VSV BMV
5 23 ND (not done)
10 41 2
20 61 11
30 7 1 26
40 88 43
50 74 ND (not done)
300-500 ng aliquots of VSV mRNA on ',ug of BMV mRNA were
translated in rabbit reticulocyte lysate; inhibition was calculated as a
percentage of acid precipitable [35S]Met cpm at 30 min. found in the
absence of oligonucleotide, less blank without mRNA. Experiments were
done at least twice, on different days.
greater than the predictions from the Fig. 2 structure. We
presume that the oligonucleotide is competing with initia-
tion factors and ribosomes for access to its target on the M
mRNA. Further probing with an oligonucleotide comple-
mentary to the ribosome binding site, and with M gene
antisense RNA of varying sizes may better identify suscep-
tible and resistant portions of the M mRNA.
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ARCHITECTURE OF PRE-MESSENGER, NUCLEAR
RIBONUCLEOPROTEIN MONOPARTICLES
J. WOOLEY,* S.-Y. CHUNG,$ J. WALL,§ AND W. LESTOURGEON'
*National Science Foundation, Washington, D.C. 20550; tNational Institutes ofHealth, Bethesda,
Maryland 20205;-Brookhaven National Laboratories, Upton, New York; and 'Vanderbilt University,
Nashville, Tennessee 37235
Nascent pre-messenger RNA transcripts in eukaryotic
nuclei are entirely associated with protein and organized
into a series of globular particles spaced by thin ribonucleo-
protein fibrils; the RNA is folded along these nuclear
ribonucleoproteins, or nRNP, to achieve a packing ratio of
at least 6:1-10:1 (1). Electron microscopic observations
and biochemical studies on nRNP argue against a simple
repeating structure similar to the chromatin fiber (1-3).
Instead, electron micrographs of nascent transcripts sug-
gest a gene-specific nRNP organization (1).
Brief ribonuclease digestion of purified mammalian
nuclei releases individual RNP complexes or monoparti-
cles, sedimenting broadly -40S, that contain pre-messen-
ger RNA (along with introns and other nRNA species)
and a set of nucleus-restricted polypeptides. The six most
abundant polypeptides species (constituting up to 90% of
the total protein mass) have been termed Al (molecular
weight 32,000 d from SDS gels), A2 (34K), BI (36K), B2
(37K), Cl(42K), and C2 (44K), respectively (2). Our
previous analyses suggest that Al, A2, and C 1 are equimo-
lar and are present at three times the abundance of B 1, B2,
and C2, which are also probably equimolar with each other
(3).
We have used biochemical methods and the scanning
transmission electron microscope (STEM) to begin a
structural characterization of human (HeLa cell) mono-
particles (isolated from purified nuclei following ribonu-
clease digestion: see references 2 and 3 for details of the
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